• Mashup Score: 2
    STOPDAPT-3: Skipping aspirin after PCI does not reduce bleeding, may raise CV risk - 8 month(s) ago

    In the STOPDAPT-3 trial, an aspirin-free strategy after PCI did not reduce major bleeding event risk compared with dual antiplatelet therapy, with data also suggesting a signal for excess coronary events, a speaker reported. DAPT with a P2Y12 inhibitor on top of aspirin therapy is the established treatment to prevent ischemic CV events, in particular stent thrombosis, at least 1 month after PCI;

    Source: www.healio.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CardiologyToday
      CardiologyToday

      The STOPDAPT-3 trial found that an #aspirin-free strategy following #PCI failed to reduce major #bleeding risk vs. dual #antiplatelet therapy. https://t.co/yaXZZAvQj5

  • Mashup Score: 3
    Aspirin - 8 month(s) ago

     What is aspirin? Aspirin is a type of medicine called a salicylate. Aspirin is used to reduce pain, inflammation (swelling), and fever. Doctors may also give their patients aspirin to treat or prevent angina, heart attacks, transient ischemic attacks (also called TIAs or “mini-strokes”), and stroke. How does aspirin work? Aspirin is an “antiplatelet,” which means that it […]

    Source: www.texasheart.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Texas_Heart
      Texas_Heart

      Considering taking a break from aspirin? 💊 According to Dr. Postalian, certain patients may still require this medication. More About Aspirin: https://t.co/mPPX4JZZWu #HeartHealth #QandA #AskADoctor #Aspirin https://t.co/WlA9CFAwGt

  • Mashup Score: 3
    Individuals With a History of Heart Disease Are Underusing Aspirin - 8 month(s) ago

    A new study found that, worldwide, aspirin is underused as a prevention measure in individuals with a history of cardiovascular disease (CVD). The findings were reported in JAMA. “Aspirin is an effective and low-cost option for reducing CVD events and improving mortality rates among individuals with established CVD. To guide efforts to mitigate the global CVD burden, there is a need to understand current levels of aspirin use for secondary prevention of CVD,” the researchers wrote. In this cross-sectional

    Source: www.docwirenews.com
    Categories: Latest Headlines, Partners & KOLs
    Tweet Tweets with this article
    • Profile photo of mydocwire
      mydocwire

      A new study found that, worldwide, aspirin is underused as a prevention measure in individuals with a history of cardiovascular disease. #CVD #heartdisease #aspirin #preventativecardiology https://t.co/tKEFFPuG90 https://t.co/QdyiIFQNTF

Load More